Open AccessChanging trends in the use of anti-vascular endothelial growth factor (anti-VEGF) biosimilars: Insights from the Vitreoretinal Society of India Biosimilars of Anti-VEGF Survey
Author(s) -
Jay Sheth,
Michael W. Stewart,
M Khatri,
Shashank Gupta,
Suraj Chawla,
Ravi Anand,
Raja Narayanan
Publication year - 2021
Publication title -
indian journal of ophthalmology/indian journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 51
eISSN - 1998-3689
pISSN - 0301-4738
DOI - 10.4103/ijo.ijo_2703_20
Subject(s) - biosimilar , ranibizumab , medicine , bevacizumab , clinical trial , pharmacology , vascular endothelial growth factor , vegf receptors , chemotherapy
The aim of this study was to present the outcomes of the 2018 and 2020 Vitreo-retinal Society of India (VRSI) biosimilars of anti-vascular endothelial growth factor (VEGF) (VIBE) surveys.